To Conserve and Protect: The Quest for Universal Vaccines

Viruses such as influenza and SARS-CoV-2 are constantly evolving to better infect their hosts. The appearance of new variants often diminishes the effectiveness of existing vaccines that were designed against pre-existing strains.

In this episode, Niki Spahich from The Scientist’s Creative Services Team spoke with Patrick Wilson, a professor at the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, to learn about strategies for making universal vaccines that account for pathogen evolution.

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Sino Biological and 10x Genomics.

Sino
Sponsored by

Sino Biological is an internationally-recognized reagent supplier and contract research organization, specializing in recombinant protein production and antibody development. Sino Biological has developed the world’s largest recombinant viral antigen bank, ProVir, which has been widely used in therapeutic antibody, vaccine, and immunodiagnostic assay development. For more information, please visit www.sinobiological.com to learn more.

This episode is brought to you by 10x Genomics, which builds solutions for interrogating biological systems at a resolution and scale that matches the complexity of biology. Their rapidly expanding suite of products, which includes instruments, consumables, and software, enables fundamental discoveries across multiple research areas, including cancer, immunology, and neuroscience.

To Conserve and Protect: The Quest for Universal Vaccines

Listen Now

TS_Podcast_TSS_August 2021_The Reality of Regenerative Medicine